Ultrastructure of Atrial Myocytes in Patients in Sinus Rhythm and With Atrial Fibrillation
NCT01493128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2017-03-13
Summary
The aim of this work is to study the prevalence of T-tubular system in left and right myocytes from patients in sinus rhythm and whether this is altered in paroxysmal and permanent atrial fibrillation. Furthermore, since current information is lacking on the key Ca2+-handling proteins RyR, NCX, and SERCA-2a from patients in Atrial Fibrillation (AF), it will be investigated whether a regulation of these proteins could be an underlying cause of the disease. Mitochondrial function will also studied.
1. The investigators hypothesize that both structure of sarcolemma and localization of key Ca2+-handling proteins are altered in patients with atrial fibrillation compared with patients in sinus rhythm.
2. The investigators hypothesize that mitochondrial function is altered in patients with atrial fibrillation compared with patients in sinus rhythm.
Conditions
Sponsors & Collaborators
-
Norwegian University of Science and Technology
lead OTHER
Principal Investigators
-
Ulrik Wisløff, PhD · Norwegian University of Science and Technology
Eligibility
- Min Age
- 50 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2012-02-29
- Completion
- 2012-07-31
More Related Trials
-
Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend
NCT05118893 ·Status: COMPLETED
-
The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT01148914 ·Status: COMPLETED
-
The Use of Flecainide for Treatment of Atrial Fibrillation
NCT05084495 ·Status: COMPLETED
-
Progression of Atrial Fibrillation in the Young
NCT05080712 ·Status: RECRUITING
-
Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study
NCT02184013 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Specific Electrophenotypes in Atrial Fibrillation
NCT05366530 ·Status: TERMINATED
-
Analysis of Endocavitary Electrical Signal and Surface Electrocardiogram to Predict Ablation Outcome in Persistent Atrial Fibrillation
NCT03937089 ·Status: COMPLETED
-
Thumb-ECG Ambulant Screening for Atrial Fibrillation in Patients Treated for Hyperthyroidism (TAMBOURINE)
NCT01945229 ·Status: TERMINATED
-
Organization of Excitation in People With Atrial Fibrillation
NCT00871390 ·Status: COMPLETED
-
Fibrosis, Inflammation and Brain Health in Atrial Fibrillation.
NCT03816865 ·Status: COMPLETED
-
Characterising the Stable and Dynamic Left Atrial Substrate in Atrial Fibrillation
NCT04229472 ·Status: COMPLETED ·Phase: NA
-
New Causes and Predictors for the Development of Atrial Fibrillation and Its Complications
NCT01863979 ·Status: COMPLETED
-
Risk Factors That Contribute to the Maintenance of Sinus Rhythm
NCT04655443 ·Status: TERMINATED
-
Prospective Evaluation of NfL as a Biomarker in ATTRv
NCT05879874 ·Status: ACTIVE_NOT_RECRUITING
-
Electrophysiological Effects of NACOS and AVK on Pulmonary Veins and Left Atrium in Paroxysmal AF Catheter Ablation
NCT02814955 ·Status: UNKNOWN
-
Waveform Periodicity Analysis of Complex Fractionated Electrograms in Patients With Persistent Atrial Fibrillation
NCT05333952 ·Status: RECRUITING ·Phase: NA
-
The Dynamics of Human Atrial Fibrillation
NCT01008722 ·Status: COMPLETED
-
Utilizing a Novel Method to Map Sources of Atrial Fibrillation
NCT02523534 ·Status: COMPLETED ·Phase: NA
-
Predicting Development of SCAF in Device Patients
NCT02808260 ·Status: RECRUITING
-
cliNIcal sCEnarios and Pathophysiology of Atrial Fibrillation
NCT04320134 ·Status: UNKNOWN
-
Echocardiographic Markers of Atrial Fibrillation Recurrence Post Radiofrequency Ablation
NCT05690529 ·Status: UNKNOWN
-
Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation
NCT01420393 ·Status: COMPLETED ·Phase: NA
-
Autoimmunity in the Pathogenesis of AF
NCT03498729 ·Status: COMPLETED
-
Node and Atrial Fibrillation Ablation for Persistent Atrial Fibrillation
NCT01057485 ·Status: UNKNOWN ·Phase: NA
-
Patient-TAILORed Ablation of Persistent AF Guided by Instantaneous Amplitude and Frequency Modulation Maps (TAILOR-AF)
NCT05169320 ·Status: UNKNOWN